These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 25204840)

  • 41. Review of the off-label use of recombinant activated factor VII in pediatric cardiac surgery patients.
    Guzzetta NA; Russell IA; Williams GD
    Anesth Analg; 2012 Aug; 115(2):364-78. PubMed ID: 22652310
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Recombinant activated factor VII (NovoSeven) treatment of platelet-related bleeding disorders. International Registry on Recombinant Factor VIIa and Congenital Platelet Disorders Group.
    Poon MC; d'Oiron R
    Blood Coagul Fibrinolysis; 2000 Apr; 11 Suppl 1():S55-68. PubMed ID: 10850567
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The use of recombinant activated factor VII in neurosurgery.
    Kapapa T; König K; Heissler HE; Schatzmann C; Tschan CA; Perl M; von Depka M; Zumkeller M; Rickels E
    Surg Neurol; 2009 Feb; 71(2):172-9; discussion 179. PubMed ID: 18295827
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Bleeding prophylaxis in a child with cleft palate and factor VII deficiency: a case report.
    Pirrello R; Siragusa S; Giambona C; D'Arpa S; Cordova A; Moschella F
    Cleft Palate Craniofac J; 2006 Jan; 43(1):108-11. PubMed ID: 16405366
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Open-heart surgery in an infant with heterozygous factor VII deficiency.
    Matsuhisa H; Yoshimura N; Niimi H; Ichida F
    Interact Cardiovasc Thorac Surg; 2010 Jun; 10(6):1037-8. PubMed ID: 20197348
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Single-center experience: use of recombinant factor VIIa for acute life-threatening bleeding in children without congenital hemorrhagic disorder.
    Yilmaz D; Karapinar B; Balkan C; Akisü M; Kavakli K
    Pediatr Hematol Oncol; 2008 Jun; 25(4):301-11. PubMed ID: 18484474
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Evaluation of prothrombin complex concentrate and recombinant activated factor VII to reverse rivaroxaban in a rabbit model.
    Godier A; Miclot A; Le Bonniec B; Durand M; Fischer AM; Emmerich J; Marchand-Leroux C; Lecompte T; Samama CM
    Anesthesiology; 2012 Jan; 116(1):94-102. PubMed ID: 22042412
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prothrombin complex concentrate versus recombinant factor VIIa for reversal of coumarin anticoagulation.
    Dickneite G
    Thromb Res; 2007; 119(5):643-51. PubMed ID: 16842841
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A novel congenital haemostatic defect: combined factor VII and factor XI deficiency.
    Bérubé C; Ofosu FA; Kelton JG; Blajchman MA
    Blood Coagul Fibrinolysis; 1992 Aug; 3(4):357-60. PubMed ID: 1420812
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Improved clot formation by combined administration of activated factor VII (NovoSeven) and fibrinogen (Haemocomplettan P).
    Tanaka KA; Taketomi T; Szlam F; Calatzis A; Levy JH
    Anesth Analg; 2008 Mar; 106(3):732-8, table of contents. PubMed ID: 18292410
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Recombinant activated factor VII following pediatric cardiac surgery.
    Kylasam S; Mos K; Fijtin S; Webster B; Chard R; Egan J
    J Intensive Care Med; 2009; 24(2):116-21. PubMed ID: 19188273
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Recombinant-activated factor VII in the paediatric cardiac surgery: single unit experience.
    Agarwal V; Okonta KE; Lal PS
    Afr J Paediatr Surg; 2012; 9(3):193-7. PubMed ID: 23250238
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Treatment of refractory bleeding after cardiac operations with low-dose recombinant activated factor VII (NovoSeven): a propensity score analysis.
    Gelsomino S; Lorusso R; Romagnoli S; Bevilacqua S; De Cicco G; Billè G; Stefàno P; Gensini GF
    Eur J Cardiothorac Surg; 2008 Jan; 33(1):64-71. PubMed ID: 17996457
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Recombinant activated factor VII as a universal haemostatic agent.
    Hedner U
    Blood Coagul Fibrinolysis; 1998 Mar; 9 Suppl 1():S147-52. PubMed ID: 9819047
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Using recombinant activated coagulation factor VII (NovoSeven) in obstetrics].
    Pekhlivanov B; Milchev N; Abrashev B
    Akush Ginekol (Sofiia); 2003; 42(6):7-9. PubMed ID: 15067806
    [TBL] [Abstract][Full Text] [Related]  

  • 56. In vitro effect of activated recombinant factor VII (rFVIIa) on coagulation properties of human blood at hypothermic temperatures.
    Kheirabadi BS; Delgado AV; Dubick MA; Scherer MR; Fedyk CG; Holcomb JB; Pusateri AE
    J Trauma; 2007 Nov; 63(5):1079-86. PubMed ID: 17993954
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Factor VII Deficiency.
    Mariani G; Bernardi F
    Semin Thromb Hemost; 2009 Jun; 35(4):400-6. PubMed ID: 19598068
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Treatment of massive cecal bleeding in a 28-Year-old patient with homozygous factor V deficiency with activated factor VII.
    Petros S; Fischer J; Mössner J; Schiefke I; Teich N
    Z Gastroenterol; 2008 Mar; 46(3):271-3. PubMed ID: 18322882
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Recombinant activated factor VII in cardiac surgery: experience from the Australian and New Zealand Haemostasis Registry.
    Dunkley S; Phillips L; McCall P; Brereton J; Lindeman R; Jankelowitz G; Cameron P
    Ann Thorac Surg; 2008 Mar; 85(3):836-44. PubMed ID: 18291152
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Recombinant factor VIIa for the prophylaxis of perioperative hemorrhage in a patient with congenital factor XI deficiency undergoing brain tumor neurosurgery.
    Sucker C; Sabel M; Stummer W; Zotz RB; Scharf RE; Gerhardt A
    Clin Appl Thromb Hemost; 2008 Oct; 14(4):472-5. PubMed ID: 18160590
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.